http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002161012-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0be8d6cfb14d04522568dd6146ad713a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-18 |
| filingDate | 2002-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09c7d55446c47f338b502233a094081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52336e4450891e248a503f629ce9eee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17f4a2b5fed5c1e0117a828aba01c8c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b69dacdab0febffa81324bcde848acbb |
| publicationDate | 2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002161012-A1 |
| titleOfInvention | Isoxazolecarboxamide derivatives |
| abstract | The invention relates to novel N-(substituted phenyl)-N′-[(ω-(3-substituted phenyl-4-isoxazolecarbonylamino)alkyl]piperazines, their N-oxides, and pharmaceutically acceptable salts thereof. The compounds are endowed with enhanced selectivity for alpha1-adrenergic receptors and a low activity in lowering blood pressure. The compounds are useful in the treatment of obstructive syndromes of the lower urinary tract, including benign prostatic hyperplasia (BPH), and in the treatment of lower urinary tract symptoms (LUTS) and neurogenic lower urinary tract dysfunction (NLUTD), and other conditions. The compounds may be administered alone or in combination with an anticholinergic compound. |
| priorityDate | 1999-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 773.